Low or high magnesium concentration in intermittent warm blood cardioplegia in patients undergoing coronary artery surgery: a prospective randomised study
ISRCTN | ISRCTN95530505 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN95530505 |
Secondary identifying numbers | PG/02/044/13713 |
- Submission date
- 23/04/2002
- Registration date
- 23/04/2002
- Last edited
- 07/06/2011
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr Massimo Caputo
Scientific
Scientific
Bristol Heart Institute
Bristol Royal Infirmary
Marlborough Street
Bristol
BS2 8HW
United Kingdom
Phone | +44 (0)117 9283145 |
---|---|
massimocaputo@hotmail.com |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | |
Study objectives | A comparison between two diferent strategies of myocardial protection. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Ischaemic heart disease |
Intervention | Patients will be randomised to: 1. 5 mmol/l Magnesium (Mg2+) 2. 16 mmol/l Mg2+) In the intermittent antegrade warm blood cardioplegia |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Specified |
Drug / device / biological / vaccine name(s) | Magnesium |
Primary outcome measure | Not provided at time of registration |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/12/2001 |
Completion date | 01/12/2004 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | 400 adult patients |
Key inclusion criteria | 1. A diagnosis of ischaemic heart disease 2. Undergoing primary myocardial revascularisation with the use of cardiopulmonary bypass and cardioplegic arrest |
Key exclusion criteria | Not provided at time of registration |
Date of first enrolment | 01/12/2001 |
Date of final enrolment | 01/12/2004 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Bristol Heart Institute
Bristol
BS2 8HW
United Kingdom
BS2 8HW
United Kingdom
Sponsor information
British Heart Foundation (UK)
Charity
Charity
14 Fitzhardinge Street
London
W1H 6DH
United Kingdom
Phone | +44 (0)20 7935 0185 |
---|---|
research@bhf.org.uk | |
Website | http://www.bhf.org.uk/ |
https://ror.org/02wdwnk04 |
Funders
Funder type
Charity
British Heart Foundation (UK)
Private sector organisation / Trusts, charities, foundations (both public and private)
Private sector organisation / Trusts, charities, foundations (both public and private)
- Alternative name(s)
- the_bhf, The British Heart Foundation, BHF
- Location
- United Kingdom
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/09/2011 | Yes | No |